↓ Skip to main content

PLOS

Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial

Overview of attention for article published in PLOS ONE, February 2013
Altmetric Badge

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
37 Mendeley
Title
Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial
Published in
PLOS ONE, February 2013
DOI 10.1371/journal.pone.0057397
Pubmed ID
Authors

Kaiyun Chen, Yong Xia, Hanning Wang, Fanglian Xiao, Guoan Xiang, Feng Shen

Abstract

Tumor recurrence is a major problem after curative resection of hepatocellular carcinoma (HCC). The current study evaluated the effects of adjuvant iodine-125 ((125)I) brachytherapy on postoperative recurrence of HCC.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 3%
Germany 1 3%
Unknown 35 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 14%
Researcher 4 11%
Student > Bachelor 4 11%
Student > Doctoral Student 3 8%
Student > Postgraduate 3 8%
Other 10 27%
Unknown 8 22%
Readers by discipline Count As %
Medicine and Dentistry 20 54%
Nursing and Health Professions 2 5%
Agricultural and Biological Sciences 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Chemistry 1 3%
Other 0 0%
Unknown 11 30%